B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Myogenesis

REACTOME PATHWAY
Reactome: R-HSA-5257935 genes29 compounds

The Myogenesis pathway (Reactome ID: R-HSA-525793) involves 5 genes and is affected by 29 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ABL1CDC42MAPK11MAPK12MAPK14

Compounds Affecting Myogenesis

#CompoundTargets HitStudies
1Sorafenib300
2Dasatinib299
3Afatinib297
4Anisomycin247
5isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
6withaferin300
7tyrphostin ag 14784
8myricetin-3-O-galactopyranoside [Supplementary Concept]300
9Quercetin300
10Axitinib298
11Crizotinib298
12Avapritinib246
13Biotin297
1419-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]300
15Imatinib Mesylate300
16triolimus [Supplementary Concept]33
17Genistein300
18pterostilbene299
19Adenosine Triphosphate300
20alpelisib227
21alsterpaullone12
22kenpaullone8
23Nocodazole Nocodazole is215
24Oxytetracycline300
25egcg300
26fisetin78
27Celecoxib295
28sp600125117
29casin10

About the Myogenesis Pathway

The Myogenesis pathway is catalogued in Reactome (ID: R-HSA-525793) and involves 5 genes. In the BiohacksAI corpus, 29 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ABL1, CDC42, MAPK11, MAPK12, MAPK14.